CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 31 - 40 of 1135
Study Number Lead Group Study Title CIRB Study Status
PBTC-061 PBTC Phase 2 Trial of G207 + 5 Gy Radiation for Children with High-Grade Gliomas Pediatric CIRB Available to Open
PBTC-059 PBTC Phase 1 Trial of Autologous HER2-specific CAR T cells in Pediatric Patients with Refractory or Recurrent Ependymoma Pediatric CIRB Available to Open
PBTC-053 PBTC A Pediatric Brain Tumor Consortium Phase I/II and Surgical Study of CX-4945 in Patients with Recurrent SHH Medulloblastoma Pediatric CIRB Available to Open
PBTC-051 PBTC Phase I Study to Evaluate the Safety and Tolerability of the CD40 Agonistic Monoclonal Antibody APX005M in Pediatric Subjects with Recurrent/Refractory Brain Tumors and Newly Diagnosed Brain Stem Glioma Pediatric CIRB Available to Open
PBTC-055 PBTC Phase I/II trial of Dabrafenib, Trametinib, and Hydroxychloroquine (HCQ) for BRAF V600E-mutant or Trametinib and HCQ for BRAF fusion/duplication positive or NF1-associated recurrent or progressive gliomas in children and young adults Pediatric CIRB Available to Open
PBTC-N14 PBTC CSF Cell-free Tumor DNA (CSF cfDNA) Liquid Biopsies for Pediatric, Adolescent, and Young Adult Patients with Primary Brain Tumors Pediatric CIRB Available to Open
PBTC-060 PBTC A Pilot Study of Safety, Tolerability, and Immunological Effects of SurVaxM in Pediatric Patients with Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma Pediatric CIRB Available to Open
PBTC-058 PBTC Phase 2 Study of Intraventricular Omburtamab-based Radioimmunotherapy for Pediatric Patients with Recurrent Medulloblastoma and Ependymoma Pediatric CIRB Available to Open
INT22-09-01 CP-CTNet_CLO-University of Wisconsin A Randomized Trial of Apalutamide in Non-Muscle Invasive Bladder Cancer Cancer Prevention and Control CIRB Available to Open
UWI20-04-01 CP-CTNet_CLO-University of Wisconsin A Dose Escalation Phase I Trial of the Safety and Immunogenicity of RG1-VLP, a Candidate Broadly Protective Vaccine for the Prevention of HPV-Associated Cancer Cancer Prevention and Control CIRB Available to Open
Displaying 31 - 40 of 1135